Format

Send to

Choose Destination
See comment in PubMed Commons below
Cleve Clin J Med. 2003 May;70(5):466-70.

Clopidogrel and thrombotic thrombocytopenic purpura: no clear case for causality.

Author information

1
Department of Internal Medicine, The Cleveland Clinic Foundation, OH 44195, USA.

Abstract

Although the antiplatelet agent clopidogrel is associated with an increased incidence of thrombotic thrombocytopenic purpura (TTP), available evidence is not sufficient to establish or disprove a causal relationship. We review and assess the evidence and case reports linking clopidogrel use with TTP and discuss how to approach the risk of TTP in patients taking clopidogrel.

PMID:
12779137
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center